Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 136
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02724644 | EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT00216255 | EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study | ||
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | ||
| NCT00955110 | Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin) | ||
| NCT00891163 | Evaluate the Depth and Duration of Anesthesia | ||
| NCT00911287 | Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain | ||
| NCT05249257 | Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity | ||
| NCT00904475 | Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain | ||
| NCT00637572 | Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss | ||
| NCT01086150 | Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy | ||
| NCT01210352 | Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT00904020 | A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain | ||
| NCT00528424 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT04681027 | Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children | ||
| NCT00904462 | Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee | ||
| NCT00911261 | Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain | ||
| NCT04607187 | Ultrasound B Mode Imaging and Elastography | ||
| NCT00528840 | Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT00266214 | Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome | ||
| NCT03428750 | Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT00913055 | Open Label Study of Octreotide Implant in Patients With Acromegaly | ||
| NCT00580294 | A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation) | ||
| NCT03774264 | Treatment Response to Xiaflex for Men With Peyronie's Disease | ||
| NCT00528606 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture | ||
| NCT03446781 | Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women | ||
| NCT00226395 | Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain | ||
| NCT01430169 | Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT00904085 | Post-operative Efficacy and Safety Study | ||
| NCT04786106 | Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | ||
| NCT03675685 | Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP | ||
| NCT04496167 | Safety and Efficacy of EN3835 in Participants With Frozen Shoulder | ||
| NCT03893890 | Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women | ||
| NCT00904202 | A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions | ||
| NCT01228071 | Time to Eugonadal Range, Time to Steady State and Drying Time | ||
| NCT01774435 | Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant | ||
| NCT01689896 | Testosterone and Pain Sensitivity | ||
| NCT03518034 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men | ||
| NCT01518907 | The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT01317641 | Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer | ||
| NCT03526549 | Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) | ||
| NCT01697384 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | ||
| NCT01316874 | Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | ||
| NCT00904540 | Topical Lidocaine Patch in Low Back Pain | ||
| NCT03120351 | Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery | ||
| NCT02006719 | Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT00260429 | Collagenase in the Treatment of Dupuytrens Disease | ||
| NCT01483963 | AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder | ||
| NCT06649539 | Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease |
